Stay updated on Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Sign up to get notified when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer's ClinicalTrials.gov revision identifier is updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T20:17:39.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    - The study page now displays a 403 Forbidden error instead of the study details, blocking access to the trial information. This reflects a permissions issue on the page that prevents viewing the study record.
    Difference
    21%
    Check dated 2026-09-22T22:17:40.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Updated the study document revision from v3.6.6 to v3.7.0, signaling a newer version of the accompanying materials.
    Difference
    0.2%
    Check dated 2026-09-15T21:40:58.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The reported change set shows no additions or deletions, indicating the page remains unchanged in this update.
    Difference
    0.1%
    Check dated 2026-09-08T18:22:46.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The study page shows a revision tag updated from v3.6.5 to v3.6.6, indicating a new version of the study documents. This is a small documentation update rather than a change to the study content or requirements.
    Difference
    0.2%
    Check dated 2026-09-01T18:17:30.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    No textual additions or deletions were provided to evaluate for this page.
    Difference
    0.2%
    Check dated 2026-08-25T19:37:16.000Z thumbnail image

Stay in the know with updates to Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.